-
June 17, 2022 Psychedelic Business Spotlight – June 17This week in psychedelic business news: ARK Invest advances deep dive into psychedelic stocks; Cybin...
-
June 10, 2022 Psychedelic Business Spotlight – June 10This week in psychedelic business news: Cybin acquires a Phase 1 DMT trial from Entheon;...
-
May 20, 2022 Psychedelic Business Spotlight – May 20This week in psychedelic business news: Another psychedelic merger; an Optimi Health acquisition; and good...
-
May 2, 2022 Elon Musk Excites Psychedelic Industry CEOs with This TweetThis is one of the billionaire's most explicit acknowledgments of the power of psychedelics for...
-
April 15, 2022 Psychedelic Business Spotlight – April 15This week in psychedelic business news: The industry's first major merger; NeonMind launches clinics; a...
-
April 12, 2022 Numinus Acquiring Novamind in First Major Psychedelics MergerThis deal will make Numinus the psychedelic medicines company with the highest revenue, though of...
-
February 4, 2022 Psychedelic Business Spotlight – February 4Levitee Labs Announces Interim CEO and Board of Directors ShuffleThis week in psychedelic business news,...
-
January 4, 2022 Health Canada Grants Special Access to Restricted Drugs for Psychedelic TherapyNew amendment reverses a 2013 Health Canada policy that prevented "a letter of authorization for...
-
December 3, 2021 Psychedelic Business Spotlight: December 3This week in psychedelic business news: MAPS pioneers new funding structure; FDA green lights a...
-
November 12, 2021 Psychedelic Business Spotlight: November 12This week in psychedelic business news: two of the biggest players in the industry unveil...
